Lumipulse® G Pepsinogen II
Piecing together the risk factors for stomach cancer
Unique mono-test immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination of Pepsinogen II in human serum or plasma.
The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
Product number 292990
Product number 233474
-
Details
Product benefits
-
Excellent precision: Typical total CV's: ≤2.8%
-
Wide dynamic range: 0.1 - 150 ng/mL
-
30-day calibration interval - no need to run a full calibration for just one sample
-
Minimal hands on time
-
Eliminates operator to operator issues associated with manual ELISA methods
-
Fast time to result - improved patient care
-
Unique mono test cartridge – excellent for low throughput assays
CLEIA - Chemiluminescent Enzyme Immunoassay
Test principle: Two-Step sandwich assay
See the LUMIPULSE G1200 working in this video:
-
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry
